Meeting Banner
Abstract #1896

Pre-Clinical MRI radiomics and machine learning to predict survival after immunotherapy treatment

Vlora Riberdy1, Alessandro Guida2,3, James Rioux1,2,3, and Kimberly Brewer1,2,3,4,5
1Physics and Atmospheric Science, Dalhousie University, Halifax, NS, Canada, 2Diagnostic Radiology, Dalhousie University, Halifax, NS, Canada, 3Biomedical MRI Research Laboratory, Nova Scotia Health Authority, Halifax, NS, Canada, 4School of Biomedical Engineering, Dalhousie University, Halifax, NS, Canada, 5Microbiology & Immunology, Dalhousie University, Halifax, NS, Canada

Synopsis

Keywords: Molecular Imaging, RadiomicsMolecular MRI allows for immunotherapy treatment monitoring of glioblastoma, but analysis of multi-parametric data is complex. Machine learning algorithms can be applied to quantitative maps, to identify correlations between radiomic features and treatment outcomes. Feature selection is key when dealing with longitudinal preclinical data with multiple contrasts and small group numbers. We evaluated three feature selection methods in terms of their ability to produce predictive models of survival. The best performance was seen using recursive feature elimination applied to features from iron concentration maps of the tumor, which yielded an ROC AUC of 0.78 and an accuracy of 0.72.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords